Esperanza Arias Selected Research

Esperanza Arias Research Topics

4	Alzheimer Disease (Alzheimer's Disease) 10/2006 - 01/2004
4	Neuroblastoma 12/2005 - 01/2004
3	Neoplasms (Cancer) 12/2021 - 10/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 05/2010
2	Carcinogenesis 11/2021 - 10/2020
2	Huntington Disease (Huntington's Disease) 12/2011 - 05/2010
1	Liver Neoplasms (Liver Cancer) 10/2020
1	Parkinson Disease (Parkinson's Disease) 04/2013
1	Starvation 08/2011
1	Reperfusion Injury 08/2007
1	Brain Ischemia (Cerebral Ischemia) 08/2007
1	Ischemia 08/2007
1	Amyloid Plaque 01/2006

4	Galantamine (Galanthamine)FDA LinkGeneric 08/2007 - 01/2004
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2013
2	Phosphotransferases (Kinase)IBA 10/2020 - 04/2013
2	Huntingtin ProteinIBA 12/2011 - 05/2010
2	Neuroprotective AgentsIBA 08/2007 - 12/2005
2	Amyloid beta-PeptidesIBA 01/2006 - 12/2005
2	AcetylcholinesteraseIBA 12/2005 - 01/2004
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2005 - 01/2004
2	Nicotine FDA Link 12/2005 - 01/2005
1	InterferonsIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Leucine (L-Leucine)FDA Link 04/2013
1	SynucleinsIBA 04/2013
1	Mutant Proteins (Protein, Mutant)IBA 12/2011
1	Melanocyte-Stimulating Hormones (MSH)IBA 08/2011
1	LipidsIBA 08/2011
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 08/2011
1	Nonesterified Fatty Acids (NEFA)IBA 08/2011
1	polyglutamineIBA 05/2010
1	MecamylamineIBA 08/2007
1	salicylhydroxamic acid (SHAM)IBA 08/2007
1	Pharmaceutical PreparationsIBA 10/2006
1	tau Proteins (tau Protein)IBA 01/2006
1	Rivastigmine (Exelon)FDA LinkGeneric 12/2005
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2005
1	Okadaic AcidIBA 12/2005
1	Donepezil (Aricept)FDA LinkGeneric 12/2005
1	Serum AlbuminIBA 09/2005
1	AlbuminsIBA 09/2005
1	CalciumIBA 09/2005
1	trkA ReceptorIBA 01/2005
1	ethyl 5- amino- 6,7,8,9- tetrahydro- 2- methyl- 4- phenylbenzo(1,8)naphthyridine- 3- carboxylateIBA 09/2004
1	Amyloid (Amyloid Fibrils)IBA 09/2004
1	ThapsigarginIBA 01/2004
1	Peptides (Polypeptides)IBA 01/2004

1	Therapeutics 12/2021
1	Immunotherapy 11/2021